Related Experiment Videos
Intravitreal U75412E: a new free radical scavenger
R Fiscella1, D A Gagliano, N S Peachey
1Department of Ophthalmology, UIC Eye Center, Chicago 60612.
Ophthalmic Surgery
|December 1, 1991
Summary
Free radical scavengers, like 21-aminosteroids, may treat eye diseases. Researchers found that the 21-aminosteroid U75412E did not harm rabbit eye tissues at tested doses.
Area of Science:
- Ophthalmology
- Pharmacology
- Toxicology
Background:
- Free-radical damage contributes to various eye diseases.
- Free radical scavenging drugs offer potential therapeutic benefits.
- 21-aminosteroids are a novel class of anti-inflammatory agents investigated as free radical scavengers.
Purpose of the Study:
- To assess the intraocular toxicity of the 21-aminosteroid U75412E.
- To evaluate the safety of U75412E for potential ophthalmic applications.
Main Methods:
- Intravitreal injections of U75412E were administered to rabbit eyes.
- Doses up to 0.1 mg were tested.
- Ocular tissues were examined for signs of toxicity.
Main Results:
- Intravitreal administration of U75412E at doses up to 0.1 mg showed no toxicity in rabbit ocular tissues.
- The compound was well-tolerated within the tested dosage range.
Conclusions:
- The 21-aminosteroid U75412E demonstrates a favorable intraocular safety profile in rabbits.
- U75412E warrants further investigation for its potential therapeutic use in ophthalmic conditions associated with free radical damage.